Notch is a highly conserved transmembrane protein that is involved in cell fate decisions and is found in organisms ranging from Drosophila to humans. A human homologue of Notch, TAN1, was initially identified at the chromosomal breakpoint of a subset of T-cell lymphoblastic leukemias/lymphomas containing a t(7;9) chromosomal translocation; however, its role in oncogenesis has been unclear. Using a bone marrow reconstitution assay with cells containing retrovirally transduced TAN1 alleles, we analyzed the oncogenic potential of both nuclear and extranuclear forms of truncated TAN1 in hematopoietic cells. Although the Moloney leukemia virus long terminal repeat drives expression in most hematopoietic cell types, retroviruses encoding either form of the TAN1 protein induced clonal leukemias of exclusively immature T cell phenotypes in "~ of transplanted animals. All tumors overexpressed truncated TAN1 of the size and subcellular localization predicted from the structure of the gene. These results show that TAN1 is an oncoprotein and suggest that truncation and overexpression are important determinants of transforming activity. Moreover, the murine tumors caused by TAN1 in the bone marrow transplant model are very similar to the TANl-associated human tumors and suggest that TAN1 may be specifically oncotropic for T cells.
T he human TAN1 gene encodes a transmembrane protein (TAN1) that contains an extracellular domain possessing a series of motifs, among which are iterated epidermal growth factor (EGF)l-like repeats, Notch/lin-12 repeats, and a pair of evolutionarily conserved cysteine residues; the intracellular portion contains ankyrin-like repeats, a glutamine-rich region, and a PEST sequence ( Fig. 1) (1) . Each of these motifs is also found in the protein product of Notch, a Drosophila melanogaster gene that appears to control cell fate decisions among equipotent progenitor cells in the developing fly (2, 3) . TAN1 is expressed at relatively high levels in developing and adult thymus, suggesting that it might participate in normal T cell development (1, 3a) .
TAN1 was originally identified through analysis of the (7;9)(q34;q34.3) chromosomal translocation found in a subset 1Abbreviations used in this paper: EGF, epidermal growth factor; FSC, forward scatter; 5-FU, 5-fluorouracil; LTI:t., long terminal repeat; MoMLV, Moloney murine leukemia virus; RIPA, radioimmunoprecipitation assay; SSC, side scatter; SCF, stem cell factor; Su(H), Suppressor of Hairless; T-ALL, T cell lymphoblastic leukemia/lymphoma; WBC, white blood cell.
of acute human T cell lymphoblastic leukemias/lymphomas (T-ALL) (1, 4) . This rearrangement fuses the 3' portion of TAN1 on chromosome 9 to the TCP,-[3 locus on chromosome 7. The resulting allele is deleted for most of the coding sequence of the extracellular domain of TAN1. It directs the synthesis of a series of truncated polypeptides of ~-,100-125 kD that have NH2-termini lying near the transmembrane domain (Aster. J., R.. Hasserjian, F. Davi, and J. Sklar, manuscript submitted for publication). The t(7;9)-specific polypeptides localize predominantly to the nucleus, probably because of two conserved nuclear localization sequences within the cytoplasmic domain of TAN1 (Aster, J., et. al., manuscript submitted for publication). Nuclear TAN1 has not been detected in cell lines expressing normal TAN1 transcripts or in developing murine thymus (3a) , raising the possibility that altered subcellular localization might influence transforming activity.
Although analysis of three tumors bearing the t(7;9) showed consistent disruption of the TAN1 gene at the chromosomal breakpoint at almost identical positions within the gene (1) , the contribution of altered TAN1 to transforma-tion is unknown. One of the three tumors studied, SUP-T1, had lost both normal TANI alleles, suggesting that TAN1 might be a tumor suppressor gene (1, 5) . Alternatively, removal of the extracellular domain of the protein by the translocation might cause constitutive activity of the intracellular domain, producing a dominant oncoprotein. The latter possibility is supported by the results of mutational analysis in Drosophila in which deletions removing the extracellular domain of Notch have been shown to lead to dominant gain-of-function phenotypes, opposite to those produced by loss-of-function mutations associated with inactivation of the gene (6) (7) (8) .
To examine whether TAN1 can function as an oncoprotein, we have used recombinant retroviruses to express, in vivo, proteins resembling the truncated polypeptides found in cells beating t(7;9). Tumors developed in ~50% of mice that received bone marrow transduced by 5' deleted forms of TAN1, In all cases, the tumors were T cell neoplasms of an immature phenotype. Expression of either cytoplasmic or nuclear forms of TAN1 resulted in a nearly identical disease. This suggests that transformation by TAN1 results primarily from overexpression and truncation of the protein, rather than subceUular localization. These results also directly implicate TAN1 in the pathogenesis of t(7;9) human T-ALL.
Materials and Methods
Retroviral Vectors and Constructs. AECT + and AECT-were constructed by llgatingJK5T, a previously described TAN1 cDNA (1), to a PCIL product spanning base pairs -14 to +70, which encodes the 5' TAN1 translational start site and signal peptide. Each construct was subcloned into the BclI site of the pGD retroviral vector (9) . The mature polypeptides encoded by AECT + and AECT-are predicted to be composed of amino acids 1673-2555 and 1704-2555 and to have NH2-termini located 61 and 30 amino acids external to the transmembrane domain, respectively. ICT was constructed by ligating an oligonucleotide containing an ATG translational start site to a unique Bsu36I site within the JK5T cDNA. The resultant construct encodes amino acids 1770--2555 and is predicted to produce a polypeptide consisting of the entire intracellular region of TAN1 minus the first 13 amino acids. Sequencing of the 3' long terminal repeat (LTR) ofpGD has shown that it is derived from the Moloney murine leukemia virus (MoMLV) LTR (M. Scott, unpublished data).
Retroviral Production and Bone Marrow Infection Protocols. Transfection of the retroviral vectors, cocultivation with 5-fluorouracil (5-FU)-treated bone marrow, and injection into lethally irradiated BALB/cByJ recipients were performed as previously described (10) . Cocultivation of the transfected Bosc23 cells and 5-FU-treated bone marrow was performed in a cocktail consisting of DME, 10% heat-inactivated FBS (JILH Biosciences, Lenexa, KS), 5% WEHI-conditioned medium, 6 U/ml recombinant mouse IL-3 (Genzyme Corp., Cambridge, MA), 10,000 U/ml recombinant mouse IL-6 (Genzyme), 5U/ml recombinant mouse stem cell factor (SCF) (Genzyme), 1 ~g/ml polybrene (Sigma Chemical Co., St. Louis, MO), 100 U/ml streptomycin (GIBCO BRL, Gaithersburg, MD), 100 U/ml penicillin (GIBCO BILL), and 2 mM t-glutamine (GIBCO BILL). Between 5 • 10 s and 1 • 10 6 nonadherent cells were injected into a tail vein of each recipient animal. Bone marrow and spleen cells from all tumors were cultured in DME supplemented with 20% heat-inactivated FBS 0ILH Biosciences), 100 U/ml streptomycin (GIBCO BRL), 100 U/nil penicillin (GIBCO BILL), 2 mM L-glutamine (GIBCO BR.L), and 4 U/ml recombinant mouse IL-2 (Genzyme). Bone marrow cells derived from mice T6, I8, and I22 adapted to continuous in vitro growth. Tumor cells from all AECT animals were readily transplantable to syngeneic mice. Transfer of ICT tumors to secondary recipients was not attempted. BALB/cByJ mice were obtained from Jackson Laboratories (Bar Harbor, ME) and maintained at the animal facilities at Rockefeller University and Massachusetts Institute of Technology under specific pathogen-flee conditions.
Protein Analysis and Immunohistochemistry. kadioimmunoprecipitation assay (ILIPA) extracts (11) were prepared from cell lines and tumors, and 10 Izg of protein was subjected to electrophoresis in 6% discontinuous SDS-polyacrylamide gels and then transferred electrophoretically to nitrocellulose membranes. The blot was probed with affinity-purified polyclonal rabbit anti-TAN1 raised against the T3 region of the cytoplasmic domain ( Fig. 1 ) and developed by a chemiluminescent method (Amersham International, Little Chalfont, Buckinghamshire, UK). DNA encoding a portion of TAN1 termed T3 (codons 1733-1877) was amplified by PCIL from JK5T (1), ligated into the vector pGEX-4T (Pharmacia), and subsequently purified from detergent lysates with glutathione-Sepharose beads (Pharmacia Biotech, Inc., Piscataway, NJ) (11) . Serum from immunized rabbits was affinity purified by sequential passage over an AflqGel-15-GST column (Bio-iLad Laboratories, Hercules, CA) and an AflqGel 15-GST-T3 column. For immunohistochemistry, sections cut from paraffin-embedded tissue were deparaffinized and boiled in a 5% urea solution for 10 min (12) . Immunoperoxidase staining was performed with affinity-purified rabbit anti-T3 according to a previously described method (13) . Slides were counterstained with hematoxylin. For staining of T6E and I22 cells, the cells were allowed to adhere to poly-r-lysine-coated slides, fixed in 3% paraformaldehyde, and permeabilized with 0.1% saponin. Indirect imnmnofluorescent and immunoperoxidase staining was performed with affinitypurified anti-T3 and secondary anti-rabbit antibody linked to FITC (Sigma) or HRP (Sigma), respectively.
Flow Cytometry. Spleen cells or LN cells were obtained from mice T8A1, I8, T3A2, T7, or age-matched controls and analyzed for forward scatter (FSC), side scatter (SSC), and expression of Thyl.2, CD4, and CD8 by multiparameter flow cytometry as described (14) . For each animal, FACS | analysis was performed on tumor samples derived from at least two different sites, and in all cases, results from the different sites were concordant (data not shown). Control spleen was obtained from an age-matched BALB/cByJ mouse. T8A1 spleen cells were derived from a mouse that had received 10 s T8 tumor cells, and T3A2 LN cells were derived from a mouse that had received 105 T3 bone marrow cells. The staining patterns of the primary T8 and T3 tumors were very similar to the patterns found in T8A1 and T3A2. Antibodies used were the following: CDSa-FITC (YTS169.4; Caltag Laboratories, San Francisco, CA), CD4-PE (YTS191.1; Caltag), TCtM3-PE (H57-597; Caltag), TCRy/8-PE (GL3; Caltag), Thyl.2-FITC (5a-8; Caltag), CD3-FITC (500-A2; Caltag), B220-PE (RA3-6B2; Caltag), MAC-1-PE (M1/70.15; Caltag), and CD24-PE (M1/69; PharMingen, San Diego, CA). Fluorescence was analyzed on a FACScan | flow cytometer with CellQuest software (Becton Dickinson, San Jose, CA).
DNA Analysis. High molecular weight DNA was isolated from fresh or snap-frozen tissues, digested with appropriate re-striction enzymes, and analyzed by Southern blot hybridization as previously described (10) . For each animal, DNA was prepared from tumors from at least two different sites. In each case, the proviral integration patterns were identical in the tissues from multiple sites (data not shown).
Results

Retroviral Expression of Truncated TAN1 in Murine Bone
Marrow Induces T-cell Neoplasms. To assess the transforming potential of truncated TAN1 in hematopoietic cells, three TAN1 cDNA constructs ( Fig. 1) were cloned into the pGD retroviral vector (9) . This retroviral vector expresses the truncated TAN1 gene under the control of the promoter dements of the MoMLV LTR.. Two constructs, AECT + and AECT-, encoded polypeptides consisting of the TAN1 signal peptide fused to sequences just external to the transmembrane domain. The major difference between these two polypeptides was that one retained a pair of evolutionarily conserved extracellular cysteines (AECT+), whereas the other did not (AECT-). Both of these constructs produced polypeptides that localized predominantly to endoplasmic reticulum and nuclear membrane when stably overexpressed in NIH 3T3 cells (Aster, J., unpublished data). The third construct, ICT, encoded most of the cytoplasmic domain of TAN1 and showed predominantly nuclear localization when transiently or stably overexpressed in murine fibroblasts (Aster, J., unpublished data). These forms were chosen for three reasons. First, the size of the encoded polypeptides (~120 kD for the AECT polypeptides and ~110 kD for ICT) roughly resembles that of the polypeptides found in cells bearing the t(7;9). Second, the different subcellular localization of the encoded polypeptides serves to test the importance of nuclear localization in transformation. Finally, comparison of AECT + and AECTmight identify a role for the conserved extracellular cysteine residues in transformation, a possibility suggested by the observation that mutation of either of these two residues in Notch produced a gain-of-function phenotype in the fly (8) .
These TAN1 constructs were individually transfected into the ecotropic retroviral packaging line, Bosc23, and the resulting high titer retroviral supematants were used to infect BALB/cByJ bone marrow in vitro (10). 10 lethally irradiated syngeneic mice received bone marrow infected with each construct. From 11 to 40 wk after transplant, 11 mice showed sudden onset cachexia and increases in their white blood cell (WBC) counts coincident with the appearance of leukemic blasts in the peripheral blood. One additional mouse, T3, became cachectic and had circulating blasts without increased WBCs (Table 1) . Tumors arose in four mice receiving AECT + bone marrow, in three mice receiving AECT-marrow, and in five mice receiving ICT marrow, suggesting that the tumorigenicity of each construct was approximately equivalent. This suggests that the presence or absence of the conserved extracellular pair of cysteine residues does not influence transforming activity. The observed frequency with which tumors arose (30-50%) is probably less than the actual frequency, as several sudden and unwitnessed deaths occurred in each group.
At necropsy, five of the mice had thymic masses, while seven mice contained only thymic remnants, the latter being consistent with postirradiation involution (Table 1) . I0 of 12 mice had lymphadenopathy and marked hepatosplenomegaly secondary to extensive infiltration and distortion by leukemic blasts (not shown). The remaining two animals, T3 and I9, had microscopic leukemic cell infiltration of spleen and liver.
TAN l-associated Tumors are Composed of Immature T cells. Flow cytometric analysis showed that each of the 12 tumors was composed of immature T cells (Fig. 2) . While all 12 tumors reacted with antibodies to Thyl.2 ( Fig. 2 (17, 18) . R.AG-2 expression was also observed in liver infiltrated by the T3 and T7 tumors (Pear, W., unpublished data). As exemplified by I8 and T3A2 (Fig. 2) , some tumors contained several subpopulations of cells with distinct immunophenotypes.
TANl-induced Tumors Contain Integrated Proviruses and Overexpress Truncated Forms of TAN1.
All tumors contained integrated proviruses, as shown by Southern (DNA) blot analysis (Figs. 3 a and 4 a) . The proviral structure was intact in nine tumors, while three contained small deletions that mapped within vector sequences flanking the cDNA inserts (see Fig. 1 ). Further blot analysis showed that 10 of 11 tumors that could be evaluated contained a single integrated provirus, while one tumor, T3, contained two unique proviral sequences (Figs. 3 b, 4 b, and data not shown). Clonal TC1K J[32 rearrangements were observed in 9 of 11 tumors evaluated (Figs. 3 c and 4 c) . Because tumor infiltration in the spleen and liver of the I9 mouse was minimal, this tumor could not be evaluated for proviral integration number or TC1K-[3 rearrangement.
All of the tumors expressed the introduced truncated forms of TAN1 at high levels relative to the levels of endogenous murine TAN1 (Notch1) in normal BALB/cByJ thymus, spleen, and liver, and the T cell line AKR (Figs. 5 a and 5 b, and data not shown). BALB/c thymus contained a protein of~120 kD (p120) (Fig. 5 a) that is derived from full-length TAN1 by proteolytic cleavage at a site just external to the transmembrane domain (Aster, J., et al., manuscript submitted for publication), p120 is closely related in primary structure to both the t(7;9)-specific polypeptides and the AECT-encoded polypeptides. It is also overexpressed by tissue culture cells transduced by a retrovirus carrying a full-length TAN1 cDNA, indicating that full-length TAN1 serves as a precursor molecule for p120 (19, Aster, J. et al., submitted). Despite its structural resemblance to oncogenic forms of truncated TAN1, p120 does not appear to be oncogenic, since none of 10 mice receiving bone marrow infected with a retrovirus expressing fulllength TAN1 developed TANl-expressing tumors over the course of 1 yr (Pear, W., andJ. Aster, unpublished data).
Both Cytoplasmic and Nuclear Forms of TAN1 Are Oncogenic. Microscopic examination of pathologically enlarged spleen, liver, and LNs showed infiltration by leukemic blasts (Fig. 6 a, and data not shown) . Immunohistochemis-try performed on these tissue sections showed a high level of T A N 1 expression in tumor cells relative to levels in surrounding normal tissue (Fig. 6 b, and data not shown) . Subcellular localization of T A N 1 was further investigated in disaggregated tumor and cell lines. Tumors induced with either A E C T construct showed prominent cytoplasmic staining with TANl-specific antibodies (Fig. 6 c, and data  not shown) . This staining colocalized with that observed using antibodies against calnexin, a protein previously shown to localize to the endoplasmic reticulum (20) . This suggests that most A E C T -p r o d u c e d TAN1 is present in the endoplasmic reticulum and contiguous portions of the nuclear membrane. In contrast, tumors induced by the I C T construct showed strong nuclear staining (Fig. 6 d, and data not  shown) .
Discussion
These studies show that truncated forms of TAN1 can induce T cell tumors in mice, strongly suggesting that Notch homologues can function as human oncogenes. T w o findings support a direct role for truncated T A N 1 in the pathogenesis of the murine T cell neoplasms. First, high level expression of the proteins encoded by retrovirally transmitted T A N 1 cDNAs occurred in all analyzable tumors. Second, a single integrated provirus was detected in most of the tumors, which were readily passaged in syngeneic recipients.
The current data, together with our previous experience using the bone marrow transplant assay, argue against other explanations for the high frequency of T cell malignancies observed in these animals. First, insertional mutagenesis by replication-competent helper virus seems unlikely, as the M o M L V envelope gene was absent from the malignant cells (Pear, W., unpublished data). Second, activation of leukemogenic endogenous retroviruses by the marrow transfer procedure itself is quite rare. Using bone marrow infected with retroviruses that carry different oncogenic and nononcogenic c D N A inserts, we have transplanted over 200 BALB/c mice. O f these animals, which have been followed for more than 1 yr after transplant, only one has developed a T cell malignancy (Pear W., and M. Scott, unpublished data).
The T cell specificity o f transformation by TAN1 is striking and probably results from the properties of the (Fig. 1) , generating a 6-kb fragment after hybridization to a TAN1 probe. The 4.4-kb fragment is the endogenous Notch1 fragment. Lanes: T6E cell line, T6 thymus, T7 thymus, BALB/c liver, T1 salivary gland, T3 spleen, T4 spleen, T7 spleen, T8 thigh mass, T14 spleen. (B) Southern blot of EcoRI-digested genomic DNA hybridized with TANI cDNA.
EcoRI cleaves once in the pGD AECT vectors (see Fig. 1 ). Lanes: T6E cell line, T6 thymus, T7 thymus, BALB/c liver, T1 spleen, T3 spleen, T4 spleen, T7 spleen, T8 thigh mass, T14 spleen. The TAN1 hybridization probe in both A and B was a 561-bp fragment that was derived by PCR from a region of the cDNA 3' of the ankyrin repeats (base pairs 6832-7393). (C) TCR I~ rearrangement in AECT tumors. DNA was digested with HindlIl. The hybridization probe is the 2,2-kb EcoRI TCR-JJ32-specific DNA fragment (37) that hybridizes to a 5-kb HindlII fragment in unrearranged DNA. Lanes: BALB/c liver, T1 spleen, T3 spleen, T4 spleen, T7 spleen, T8 thigh mass, T14 spleen, T6E cell hne. 5-10 ~g of DNA was loaded in each lane except T6 thymus, where 2 ~g was loaded. Size markers, in kilobases, are to the left. (38) . A faint band in the identical position was observed in all other AECT tumor extracts upon longer exposure (not shown). Lanes: Jurkat, a human T-ALL with apparently nomaal TAN1 alleles, SUPTI, a human T-ALL cell line with two copies of the t(7;9) and no normal T A N I allele, BALB/cByJ thymus, T1 spleen, T3B2 spleen (secondary transplant recipient of cells from T3 spleen), T4 spleen, T6 thymus, T6E cell line, T8 thigh mass, TI4A1 spleen (secondary transplant recipient of cells from TI4 spleen). (B) Western blot showing TAN1 expression in tumors from ICT transplants. The ICT TANI specific product is present at ~110 kD. A similar band was present in 146 spleen (Aster, J., unpublished data). The HI 10-kD band was not detectable in 19 spleen owing to the small amount of tumor present in the liver and spleen of this animal. The band at ~'350 kD in the I22 cell line (lane 5) corresponds in size to the product of murine Notchl (38) . A faint band in the identical position was observed in all other ICT tumor extracts upon longer exposure. The ~120-kD TANl-specific band corresponding to the proteolytic cleavage product is present in BALB/c thymus upon longer exposure. Lanes: 1, BALB/c spleen; 2, BALB/c thymus; 3, I2I liver; 4, I22 spleen; 5, I22 cell line; 6, I8 liver; 7, 18 spleen; 8, I9, spleen. 10 I*g of protein was loaded in each lane. The size markers, in kD, are to the left. Unlike several other genes implicated in the pathogenesis of T-ALL, including TALI, RBTN2, and HOX11, which are not normally expressed in thymocytes (26) (27) (28) (29) , Notch 1~TAN1 is expressed at high levels in normal thymus (1) and is also expressed in CD34 + stem cells within the bone marrow (30) . The highest levels of TAN1 expression in routine and human thymus occur in cortical thymocytes (3a) , and all of the TANl-associated tumors described in this report have immunophenotypes resembling those of normal cortical thymocytes. The normal function of TAN1 in T cells and marrow progenitor cells is unknown. However, recent developmental studies in flies, frogs, and cultured routine cells have shown that truncated forms of Notch-related proteins inhibit certain programs of differentiation (2). For example, truncated Notch1 inhibits neurogenesis and myogenesis of routine embryonal carcinoma cells (31, 32) . These and other observations support the idea that Notch expression maintains various cell types in a less differentiated state (3, 33) . Our studies suggest that truncated TAN1 might act in a similar fashion within T cell progenitors by preventing their terminal differentiation and predisposing them to malignant transformation.
The apparent ability of truncated TAN1 to transform regardless ofsubcellular localization is puzzling, Although it is possible that a small amount of nuclear protein in the AECT tumors is responsible for transforming activity (or that a small amount of cytoplasmic protein is culpable in ICT tumors), it is noteworthy that functional equivalence of cytoplasmic and nuclear forms of truncated Notch has also been observed in a number of other systems, particularly those assessing effects on eye, wing, and bristle development in the fly (7, 8) . AECT-like polypeptides also perturb myogenesis and neurogenesis in developing frogs (34) . One possible explanation for the functional equivalence of cytoplasmic and nuclear Notch proteins would involve interaction with downstream factors that normally shuttle between the nucleus and the cytoplasm. Candidate proteins include several transcription factors that are believed to interact with Notch on on the basis of genetic data (2) . The subcellular localization of one molecule, Suppressor of Hairless (Su(H)), appears to be controlled by activation of Notch through binding ofligand to the extracellular domain. This suggests that Su(H) participates in Notch signaling in some cell types in the fly (35) . A mammalian homologue of Su(H), CBFI (also known as RBP-J kappa), has been shown to activate transcription following interaction with murine Notch1 (36) . Preliminary results show that Su(H) interacts with both the AECT and ICT proteins (Aster, J., unpublished data), suggesting that this molecule is involved in neoplastic signaling in these tumors. Elucidation of this signalling pathway and the activated genes awaits further analysis.
